- Home
- VRAX vs BHV Comparison
VRAX vs BHV Comparison
Compare VRAX & BHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- BHV
- Stock Information
- Founded
- VRAX 2013
- BHV 2002
- Country
- VRAX United Kingdom
- BHV United States
- Employees
- VRAX N/A
- BHV N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BHV Finance/Investors Services
- Sector
- VRAX Health Care
- BHV Finance
- Exchange
- VRAX Nasdaq
- BHV Nasdaq
- Market Cap
- VRAX 17.2M
- BHV 17.5M
- IPO Year
- VRAX 2022
- BHV N/A
- Fundamental
- Price
- VRAX $2.80
- BHV $11.54
- Analyst Decision
- VRAX
- BHV
- Analyst Count
- VRAX 0
- BHV 0
- Target Price
- VRAX N/A
- BHV N/A
- AVG Volume (30 Days)
- VRAX 13.0M
- BHV 3.5K
- Earning Date
- VRAX 11-06-2024
- BHV 01-01-0001
- Dividend Yield
- VRAX N/A
- BHV 3.35%
- EPS Growth
- VRAX N/A
- BHV N/A
- EPS
- VRAX N/A
- BHV N/A
- Revenue
- VRAX $156,419.00
- BHV N/A
- Revenue This Year
- VRAX $5,169.18
- BHV N/A
- Revenue Next Year
- VRAX $66.97
- BHV N/A
- P/E Ratio
- VRAX N/A
- BHV N/A
- Revenue Growth
- VRAX 1727.11
- BHV N/A
- 52 Week Low
- VRAX $0.60
- BHV $8.85
- 52 Week High
- VRAX $9.00
- BHV $12.08
- Technical
- Relative Strength Index (RSI)
- VRAX 46.62
- BHV 65.35
- Support Level
- VRAX $2.40
- BHV $11.11
- Resistance Level
- VRAX $3.26
- BHV $11.60
- Average True Range (ATR)
- VRAX 0.75
- BHV 0.06
- MACD
- VRAX -0.31
- BHV 0.02
- Stochastic Oscillator
- VRAX 9.18
- BHV 87.76
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About BHV BlackRock Virginia Municipal Bond Trust
Blackrock Virginia Municipal Bond Trust is a perpetual closed-end municipal bond fund. Its objective is to provide current income exempt from regular Federal income taxes and Virginia personal income taxes. The company invests on behalf of its clients from large institutions to parents and grandparents, teachers, nurses, doctors and people from all walks of life who entrust their savings to the company.